Stratifying the MWS analysis by age at diagnosis of breast cancer, we observed that among carriers of BRCA1 and BRCA2 PTVs, the odds ratio (OR) for breast cancer aged <55 (vs controls) was more than double that of breast cancer aged ≥55. This evidence concerns the gene BRCA2 and breast cancer.